Megatherapy combining I131 metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma

Bone Marrow Transplantation

Volumn 27, Issue 6, 2001, Pages 571-574

  Miano, M ^a   Garaventa, A ^a   Pizzitola, M R ^a   Piccolo, M S Lo ^a   Dallorso, S ^a   Villavecchia, G P ^b   Bertolazzi, C ^c   Cabria, M ^b   De Bernardi, B ^a  

^a G GASLINI INSTITUTE   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c Nuclear Medicine San Biagio Hospital   (Italy)

Author keywords

I131 metaiodobenzylguanidine; Neuroblastoma; Peripheral blood stem cell transplantation; Toxicity

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; BUSULFAN; MELPHALAN;

ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CHILD; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; FATALITY; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LUNG COMPLICATION; MALE; MINIMAL RESIDUAL DISEASE; MUCOSA INFLAMMATION; NEUROBLASTOMA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

3-IODOBENZYLGUANIDINE; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; IODINE RADIOISOTOPES; LUNG DISEASES, INTERSTITIAL; MALE; NEUROBLASTOMA; RADIOPHARMACEUTICALS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 0035029394     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702846     Document Type: Article

References (15)

1. Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cisretinoic acid
2. Treatment of neuroblastoma with 131 I-MIBG: Dosimetric problems and prospectives
3. Regimen related toxicity in patients undergoing bone marrow transplantation
4. Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions
5. Radioresistant sensitization of neuroblastoma by cisplatin
6. 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma
7. 131I]metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastoma
8. 131I-meta-iodo-benzylguanidine, high dose chemotherapy and immunotherapy. A pilot study
9. Early deaths in children with HSCT. Bone Marrow Transplantation Group of the Italian Association for Pediatric Haematology and Oncology (AIEOP) and Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
10. Survival after cytomegalovirus pneumonia in two children receiving autologous peripheral blood progenitor cell transplantation (PBPCT)
11. 131I-MIBG) therapy for residual neuroblastoma: A mono-institutional experience with 43 patients
12. 131-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas
13. 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma
14. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: A report from the European Bone Marrow Transplantation Solid Tumor Registry
15. Late effects of total body irradiation